webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

2,5-Dioxopyrrolidin-1-yl 4-((2-((2-(2-(4-(2,6-Dioxo-1,3-Dipropyl-2,3,6,9-Tetrahydro-1H-Purin-8-Yl)phenoxy)acetamido)ethyl)amino)ethyl)disulfanyl)-4-Oxobutanoate

  CAS No.: 1222787-24-7   Cat No.: BADC-00528 4.5  

2, 5-Dioxopyrrolidin-1-yl 4-((2-((2-(2-(4-(2, 6-dioxo-1, 3-dipropyl-2, 3, 6, 9-tetrahydro-1H-purin-8-yl)phenoxy)acetamido)ethyl)amino)ethyl)disulfanyl)-4-oxobutanoate is a linker for antibody-drug-conjugation (ADC).

2,5-Dioxopyrrolidin-1-yl 4-((2-((2-(2-(4-(2,6-Dioxo-1,3-Dipropyl-2,3,6,9-Tetrahydro-1H-Purin-8-Yl)phenoxy)acetamido)ethyl)amino)ethyl)disulfanyl)-4-Oxobutanoate

Structure of 1222787-24-7

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C31H39N7O9S2
Molecular Weight
717.81
Shipping
Room temperature, or blue ice upon request.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Canonical SMILES
CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC=C(C=C3)OCC(=O)NCCNCCSSC(=O)CCC(=O)ON4C(=O)CCC4=O
InChI
InChI=1S/C31H39N7O9S2/c1-3-16-36-29-27(30(44)37(17-4-2)31(36)45)34-28(35-29)20-5-7-21(8-6-20)46-19-22(39)33-14-13-32-15-18-48-49-26(43)12-11-25(42)47-38-23(40)9-10-24(38)41/h5-8,32H,3-4,9-19H2,1-2H3,(H,33,39)(H,34,35)
InChIKey
BCDTTXGAJHVPDS-UHFFFAOYSA-N
Shipping
Room temperature, or blue ice upon request.

One of the key applications of 2,5-Dioxopyrrolidin-1-yl 4-((2-((2-(2-(4-(2,6-Dioxo-1,3-Dipropyl-2,3,6,9-Tetrahydro-1H-Purin-8-Yl)phenoxy)acetamido)ethyl)amino)ethyl)disulfanyl)-4-Oxobutanoate is in drug development and pharmaceutical research. This compound can serve as a scaffold or intermediate in the synthesis of drugs targeting various biological pathways. The purine moiety in its structure is particularly significant because purine derivatives are well-known for their bioactive properties, being essential constituents in compounds that can interact with nucleic acids and proteins. This makes the compound valuable for creating new therapies aimed at treating diseases such as cancer, viral infections, and inflammatory conditions.

Another important application is in biochemical research, specifically in the study of enzyme mechanisms and protein interactions. The presence of both a disulfide bond and an oxobutanoate group in the compound makes it a useful probe for investigating redox reactions and thiol-disulfide exchange processes in biological systems. Researchers can use it to label, track, and understand the behavior of proteins and other biomolecules under various conditions, shedding light on intricate cellular processes and potentially leading to the identification of new therapeutic targets.

The compound also finds application in the development of diagnostic tools and assays. Due to its complex structure, bearing multiple functional groups, it can be engineered to act as a reporter molecule or a binding agent in various diagnostic platforms. For instance, it can be used in assays designed to detect specific biomolecules or pathological changes in biological samples, contributing to the early and accurate diagnosis of diseases. Its ability to bind selectively and specifically to certain targets enhances the sensitivity and specificity of diagnostic tests.

Lastly, 2,5-Dioxopyrrolidin-1-yl 4-((2-((2-(2-(4-(2,6-Dioxo-1,3-Dipropyl-2,3,6,9-Tetrahydro-1H-Purin-8-Yl)phenoxy)acetamido)ethyl)amino)ethyl)disulfanyl)-4-Oxobutanoate is utilized in molecular biology and genetic engineering. The compound’s intricate structure allows it to be incorporated into probes or primers used in techniques like PCR (Polymerase Chain Reaction) and DNA sequencing. These applications are critical for genetic analysis and manipulation, helping researchers to understand genetic codes, identify mutations, and engineer genetic modifications. This contributes significantly to advancements in fields such as agriculture, biotechnology, and personalized medicine.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: APN-PEG4-tetrazine | Tubulysin IM-2 | Mc-Val-Cit-PABC-PNP | MC-Val-Cit-PAB-MMAE | MMAE | BCN-endo-PEG7-maleimide | BCN-endo-PEG7-NH2 | Azido-PEG4-PFP ester | Mal-amido-PEG8-acid | Luteolin 7-O-glucoside | 2,5-Dioxopyrrolidin-1-yl 4-((2-((2-(2-(4-(2,6-Dioxo-1,3-Dipropyl-2,3,6,9-Tetrahydro-1H-Purin-8-Yl)phenoxy)acetamido)ethyl)amino)ethyl)disulfanyl)-4-Oxobutanoate
Send Inquiry
Verification code
Inquiry Basket